Clinical trial
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers
NCT07791199
Study timeline
Study start (estimated)2026-12-31Date precision: day
Registry last updated2026-09-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Systemic Lupus Erythematosusunresolved
Sjögren's Diseaseunresolved
Psoriasisunresolved
Psoriatic Arthritisunresolved
Interventions
DeucravacitinibDRUG · verified · RxNorm: deucravacitinib
Sponsors & collaborators
Bristol-Myers Squibblead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07791199 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.